Endocrinology (diabetes mellitus) Flashcards
diagnosis and treatment
What are the main differentials for diabetes mellitus in an old cat losing weight
Main causes of weight loss in an older cat are:
- renal disease
- neoplasia
- hyperthyroidism
- inflammatory bowel disease
Explain what is stress hyperglycemia observed in cats and why is it important to recognize
Cats can suffer from stress-associated hyperglycemia which can cause glycosuria
in some cases, the stress-induced hyperglycemia can last for up to three days
for this reason, a single blood or urine sample cannot be considered as diagnostic of diabetes
How can you differentiate stress-induced hyperglycemia from real chronic hyperglycemia
Diagnostic options include:
1/ Repeat blood glucose
- repeat blood glucose measurements to show that the hyperglycemia is persistent
- place a continuous glucose monitoring device to measure interstitial glucose concentration and eliminate stress
2/ Urine collection at home
- home monitoring of urine glucose can be helpful in the diagnosis of diabetes and may also provide valuable monitoring information
- the urine sample can be tested for glucose (and ketones), and if this is persistently positive, the diagnosis is confirmed
3/ Fructosamine concentrations
- This gives a more accurate reflection of the long-term blood sugar levels
- fructosamine is a glycosylated serum protein molecule produced by a non-enzymatic reaction between glucose and the amino groups of plasma proteins
- the concentration of fructosamine depends on glucose concentrations for the preceding 2 weeks and the circulating half-lives of plasma proteins
- elevation in serum fructosamine indicates that there has been significant hyperglycemia during the previous 2 weeks
- hyperthyroidism and hypoproteinemia will artifactually reduce the fructosamine concentration
- serum fructosamine estimation is helpful as a long term monitoring test in cats receiving treatment for their diabetes but it cannot identify a Somogyi event
What are the goals of diabetes mellitus treatment
resolution of clinical signs associated with diabetes (PU/PD, polyphagia, weight loss being the major ones)
production of a normal blood glucose
successful treatment should be associated with prevention/minimisation of ketoacidosis, hypoglycemia and the development of long-term complications such as peripheral neuropathies
blood glucose of less than 14 mmol/l (252 mg/dl) throughout the day usually achieves these aims
What is the initial management of diabetes mellitus in a cat treated with prednisolone or progestogen
initial management should address factors that have precipitated or complicated diabetes (e.g., withdrawal of diabetogenic drugs)
- if diabetogenic drugs have been used (prednisolone, progestogens, …), these should be withdrawn as quickly and safely as possible
- if treatment is started and other drugs are removed, careful close monitoring is needed as insulin requirements may decline markedly over time
- consideration of the introduction of alternative immunosuppressive agents such as chlorambucil or cyclosporine may provide a better alternative
explain dietary management of diabetes
management of obesity
- obese diabetic cats should be put onto a weight loss regime as obesity causes insulin resistance
- a low carbohydrate diet may be optimal
- underweight diabetic cats may need energy-dense diets until their weight normalises
optimum diet for diabetic cats
- studies have consistently shown benefits in feeding cats a high protein, low-carbohydrate diet
- they improve the glycemic control, reduce insulin requirements and in a proportion of cats such diets appear to be able to reduce/eliminate the need for insulin therapy completely
- it is essential to change diet slowly and to monitor the patient carefully since insulin requirements can change very quickly
given the absence of a psot-prandial hyperglycemia, timing of meals is not critical in feline diabetic patients
explain how and why glipizide can be used as an oral medication for diabetes
between 20-30% of feline diabetics may potentially respond well to oral hypoglycemics
glipizide has a variety of effects:
- stimulates insulin secretion by any remaining functional beta cells in the pancreas
- improves insulin effectiveness by increasing the number and sensitivity of insulin receptors on peripheral cells
it may take 4-8 weeks before the full effects of glipizide therapy are seen
an initial dose of 2.5 mg/cat PO BID may be used, increasing to 5 mg BID if the response has been inadequate after the first 2-4 weeks
explain the concept of beta cell exhaustion and glucose toxicity
diabetes is characterised by absolute or relative insulin deficiency and persistent hyperglycemia
the persistent stimulus for insulin secretion can lead to the phenomenon of beta-cell exhaustion, where the functioning beta-cells are just not able to keep up with the demand for insulin and beyond this, there is also a phenomenon of glucose toxicity
glucose toxicity describes the situation whereby prolonged hyperglycemia initially suppresses insulin secretion through beta-cell exhaustion (which is completely reversible) but subsequently
glucose toxicity and beta-cell exhaustion are thought to be part of the reason why glipizide may take some time to exert its maximal effect in treated cats
this mechanism argues strongly for the use of exogenous insulin in the initial stages of treating all cats with diabetes so that the hyperglycemia can be rapidly reversed and any damage to beta-cells caused by hyperglycemia halted while allowing remaining beta-cells to recover their maximal function
List the main limitations and adverse effects of glipizide
if the underlying cause of the diabetes is progressive, additional loss of functioning beta-cells may eventually result in poor control even in cases that responded well initially
it has been suggested that the increased stimulation of residual beta-cells by glipizide may just hasten the progression of the disease as increased insulin secretion will be accompanied by increased amyllin secretion
adverse effects are seen in some glipizide-treated cats and these include:
- vomiting (which can be transient)
- hypoglycemia
- hepatotoxicity
what are incretins and how are they helpful in diabetes management
incretins are gastro-intestinal hormones involved in glucose homeostasis that are released secondary to food intake
incretins increase glucose-dependent insulin secretion and can stimulate pancreatic beta-cell proliferation
they inhibit glucagon secretion, slow gastric emptying and induce satiety
examples of incretins include glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
what can you say about insulin therapy in cats
in contrast to humans most cats are actually insulin dependent
- the reason may be because the disease is usually considerably more advanced in cats when a diagnosis is made
in most cats, insulin therapy is the most effective treatment for their diabetes
in terms of antigenicity, feline insulin is most closely related to bovine insulin (only one amino acid difference), whereas porcine and human insulin have 3 and 4 amino acid differences respectively
What is the aim of insulin therapy
treatment of cats with exogenous insulin is aimed at controlling the major clinical signs of disease (weight loss, PU/PD) rather than maintaining normoglycemia
in most cats, there are few if any, long-term consequences of mild hyperglycemia, and thus tight glycemic control is generally not needed
- one exception to this general rule is when diabetic neuropathy has developed. In this situation, it may be necessary to try to improve glycemic control to a greater extent
maintaining glucose concentrations below the renal threshold during the majority (>50%) of a 24-hour period will likely produce very satisfactory results in most diabetic cats
List insulin choices and characteristics in cats
long-acting insulin
- PZI:
1/ unpredictbale onset and duration of action
2/ there can be problems with absorption in some cats
- Ultralente:
1/ response is considerbly less predictable than PZI
2/ some cats appear to need high doses for glycemic control
- Glargine:
1/ considered to be a very good choice in cats, especially those that are newly diagnosed
2/ its long duration of action means that generally glycemic peaks and throughs are minimised thus reducing beta-cell glucose toxicity
3/ it is preferable to dose twice daily
intermediate acting
- NPH
1/ needs twice daily dosing but onset and duration of response more predictable than long-acting preparations
2/ may have a too short duration to be used even twice daily
- Lente (e.g. caninsulin)
1/ requires twice daily dosing for glycemic control but rarely has too short a duration when used this way
2/ onset and duration of action more predictable than long-acting preparations
short-acting
Soluble insulin
1/ not suitable for long-term management due to its short duration of action
2/ very useful in the management of diabetic ketoacidosis
what is the pecularity of cats regarding insulin
cats appear to metabolise insulin more rapidly than some other species therefore dosing twice a day seems better whatever the insulin used
insulin sensitivity is inherently lower in male cats
a considerable individual variation occurs with regards to the duration of action (in some cats, PZI insulin may last more than 36 hours)
the considerable individual variability in response to insulin and duration of action means that careful individual titration of dose and type of insulin therapy should always be performed
how would you initiate insulin therapy in a newly diagnosed diabetic cat
Non-ketotic diabetic cats should be started on insulin at a dose between 0.25 and 0.5 units per kg bodyweight with 0.5 U/kg being used for cats with glucose > 20 mmol/l (glu>3.6 g/l)
- the dose is rounded down to the nearest unit and is generally < 2 U/cat q 12h
- obese and underweight cats should be dosed according to their estimated ideal weight
how is insulin therapy monitored
the response to insulin therapy should be monitored using clinical (polydipsia, body weight, …) and laboratory parameters
an interstitial continuous glucose monitoring device (e.g. Freestyle libre) can be used in euhydrated patients
initially, it is prudent to measure blood glucose immediately priori to insulin administration and then with one or two measurements around the time of estimated peak insulin activity (around 4 hours post-injection for lente insulin, and typically around 8 hours post-injection for PZI insulin)
blood testing for monitoring of glargine administration is ideally performed every 2-4 hours
typically, on the third or fourth day, a blood glucose curve is performed
what are the aims of a blood glucose curve
the main aims of a blood glucose curve are:
1/ to determine the time of peak action of the insulin (glucose nadir)
2/ to ascertain the duration of the insulin’s action
3/ to determine the trough glucose measurement (=the lowest blood glucose level after insulin injection)
what will be an ideal blood glucose curve
the blood glucose should drop to around 5-9 mmol/l (90-162 mg/dl) at the nadir
spend the majority of the 12- or 24-hour period of the curve below renal threshold (around 14 mmol/l or 250 mg/dl)
it is important that the glucose nadir does not drop below 4-5 mmol/l or there may be a risk of hypoglycemia when the patient is less closely monitored